missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human VIPR2 Fc Chimera Protein
Click to view available options
Quantity:
50 μg
Unit Size:
50µg
Description
Measured by its binding ability in a functional ELISA. When Recombinant Human Growth Hormone-Releasing Factor is immobilized at 2.00 μg/mL, 100 μL/well, Recombinant Human VIPR2 Fc Chimera binds with an ED50 of 7.00-42.0 μg/mL.
Specifications
Specifications
| Accession Number | P41587.2 |
| For Use With (Application) | Bioactivity |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. |
| Gene ID (Entrez) | 7434 |
| Molecular Weight (g/mol) | MolecularWeight-observed: 45-60 kDa, under reducing conditions.; MolecularWeight-theroretical: 38 kDa |
| Quantity | 50 μg |
| Source | Human embryonic kidney cell, HEK293-derived human VIPR2 protein Recombinant Human VIPR2 (Arg26-Val126) (N-terminus) Accession # P41587.2 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus) |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Gene Alias | FLJ16511, Helodermin-preferring VIP receptor, PACAP type III receptor, PACAPR3, PACAP-R3, PACAP-R-3, Pituitary adenylate cyclase-activating polypeptide type III receptor, vasoactive intestinal peptide receptor 2, vasoactive intestinal polypeptide receptor 2, VIP R2, VIP2R, VIP-R-2, VPAC2, VPCAP2R |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction